Time-dependent cytokine landscapes in an ex vivo microfluidic glioblastoma platform

In brief

This study presents a novel ex vivo microfluidic platform that preserves native glioblastoma architecture while enabling time-dependent cytokine profiling. The model addresses critical limitations in current GBM research by maintaining the tumor microenvironment, offering improved preclinical testing capabilities for this aggressive brain cancer with poor prognosis.

Written by the GCMD Library team from the article.